Sensai
Reading the tape…Pulling live market data…Setting the scene…
Sensai
AI Stock Dissection
AI Stock Dissection
GLAND
Mr. Srinivas Sadu · Hyderabad, India
₹2,517.00
▼-1.05%GLAND continues to trade relatively flat, defying its analyst consensus 'Buy' status, as profit margin and debt level concerns temper enthusiasm around its strong revenue growth.
Exchange
NSI
Currency
INR
Day range
₹2,493.00 – ₹2,586.00
52-week range
₹1,573.60 – ₹2,586.00
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
AI investment rating
AI analysis80% confidence
We consider GLAND's valuation to be slightly elevated due to its P/E ratio trading within the upper third of its 1-year range, though attractive growth prospects support a long-term accumulation position.
2.7% below the 1-year high · trend down
Hedge-fund memo
Today
GLAND declined 1.05% amidst thin volumes, but remains above its 21-day moving average.
This week
Currently trading within its day range of 2493-2586, the stock has formed a minor resistance at its 52-week high.
This month
July's average price has seen a minor decrease, but the company's revenue growth remains impressive.
Bull thesis
Bear thesis
Narrative read
Neutral
Composite sentiment
Institutional
Neutral (34.01% institutional holdings support the market, but cautiousness prevails)
Retail
Cautionary (retail investors may be taking a wait-and-see approach, despite favorable growth prospects)
News flow
Neutral (GLAND's latest developments have received relatively little attention in recent news reports)
Read
Market participants are watching the company's growth trajectory closely, awaiting a decisive move to reassess valuation.
Live news feed unavailable right now — showing the AI's qualitative read instead. Not scraped platform data.
Smart money
Named holders aren't published for this listing (common for Indian stocks). The split at left is live.
Financial health
Profitability
Growth
Balance sheet
Financial statements
Earnings intelligence
Beat estimates in 3 of 4 recent quarters (EPS actual vs. consensus).
22.23 vs 15.7775
40.90% surprise
16.9762 vs 14.38714
18.00% surprise
11.15 vs 12.965
-14.00% surprise
Competitive landscape
| Company | Market cap | P/E | ROE | Op. margin | Rev. growth |
|---|---|---|---|---|---|
| GLAND | 419.61B | 40.92 | 10.53% | 23.20% | 22.30% |
| ALKEM | 695.45B | 30.25 | 17.56% | 11.42% | 14.60% |
| LAURUSLABS | 962.46B | 87.71 | — |
Technical intelligence
Volume
RSI (14) · 70 overbought / 30 oversold
MACD (12,26,9) · MACD vs signal
Candlesticks, volume, RSI and MACD from 499sessions of real Yahoo daily data. Moving averages use full history, so they're accurate at the left edge. Support / resistance are the 52-week low / high. Educational — technical signals are not buy or sell calls.
Risk intelligence
Debt servicing and capital adequacy concerns
Mitigation: GLAND could improve its debt coverage ratio by generating cash through asset sales or increasing equity capital.
Business intelligence
Competitive moat
GLAND's extensive research and development focus, along with its robust regulatory compliance, has given it a durable competitive advantage in the market.
Supply chain
Upstream (inputs / suppliers)
↓
Downstream (customers / markets)
M&A / strategic moves
No notable recent activity flagged.
Catalyst calendar
A major product launch or expansion into a new market
Thesis builder
Bull case
The company will continue to drive growth through strategic expansion and innovation, yielding higher profit margins, and solidifying its market position.
Base case
GLAND's moderate growth trajectory, bolstered by revenue growth and expansion plans, supports a stable accumulation stance.
Bear case
Rising financial risks, stagnant profit margins, and a competitive market could lead to a decline in the stock's value and impact shareholder returns.
Time horizon
12-18 months
Est. CAGR
15-18%
Entry (qual.)
When debt-to-equity levels start to normalize and the company demonstrates sustained revenue growth amidst a stable profit margin performance.
Exit (qual.)
On signs of increased competition in the market, a deterioration in profit margins, or any significant rise in debt levels.
Knowledge graph
Executives & sector are live; peers are clickable → their dissection. Institutional holders shown where the exchange publishes them.
Portfolio impact
Enter tickers + weights, then see how GLAND fits.
Scenario simulator
Simulate a macro shock and see the illustrative impact:
Tailwind for tech & enablers.
Illustrative impact
Medium prob.Directional illustration only — not modelled on this company's actuals. A real simulator needs company financials.
Explain like…
Re-explain GLAND for a different audience:
Pick a persona to get a tailored explanation.
Sensai publishes educational market commentary, not investment advice. We are not SEBI-registered investment advisers or research analysts, and nothing here is a recommendation to buy, sell, or hold any security.
Live prices, index levels, and other market data are pulled from third-party feeds, may be delayed, and can be inaccurate or unavailable. Do not rely on them for trading decisions.
Investing in equities carries risk, including the loss of principal. Always do your own research and consider consulting a SEBI-registered adviser before making any investment decision.
Hidden risks
—
Hidden opportunities
—
Watch next
—
Investors should cautiously accumulate GLAND for the longer term, weighing growth prospects against current valuation and financial risks.
Annual income statement, oldest → newest. Live via Yahoo.
13.3268 vs 13.278
0.37% surprise
| 25.39% |
| 29.10% |
| LALPATHLAB | 313.72B | 58.02 | — | 25.46% | 19.10% |
Peers via Yahoo's similarity graph, same-sector first; fundamentals live. Ask the AI copilot below for a qualitative head-to-head.
Support (day/52w low)
₹2,493.00
Resistance (day/52w high)
₹2,586.00
Volume
7,45,891
Trend
down
RSI (14)
57
MACD
bearish
MA cross
golden
50-day MA
₹2,351.78
200-day MA
₹1,920.07
vs 200-DMA
31.1%
RSI/MACD computed from 6 months of daily closes; moving averages from Yahoo. Options positioning still needs an options feed.
Overall conviction 80%